Equity

BGF Next Generation Health Care Fund

Emerging markets are generally more sensitive to economic and political conditions than developed markets. Other factors include greater 'Liquidity Risk', restrictions on investment or transfer of assets, failed/delayed delivery of securities or payments to the Fund and sustainability-related risks. Investment risk is concentrated in specific sectors, countries, currencies or companies. This means the Fund is more sensitive to any localised economic, market, political, sustainability-related or regulatory events. The value of equities and equity-related securities can be affected by daily stock market movements. Other influential factors include political, economic news, company earnings and significant corporate events. The Fund seeks to exclude companies engaging in certain activities inconsistent with ESG criteria. Investors should therefore make a personal ethical assessment of the Fund’s ESG screening prior to investing in the Fund. Such ESG screening may adversely affect the value of the Fund’s investments compared to a fund without such screening.

Overview

Loading

Performance

Performance

Chart

View full chart
  1y 3y 5y 10y Incept.
6.28 5.68 - - 1.31
0.97 3.89 - - 0.11
Benchmark (%) 7.58 14.00 - - 9.61
  YTD 1m 3m 6m 1y 3y 5y 10y Incept.
9.26 7.55 18.49 25.10 6.28 18.03 - - 5.78
3.79 2.18 12.57 18.85 0.97 12.13 - - 0.49
Benchmark (%) 8.03 -0.56 6.84 12.45 7.58 48.15 - - 48.42

  2020 2021 2022 2023 2024
Total Return (%) -15.57 2.73 9.18
Benchmark (%) -13.01 18.06 25.33
Performance of the Fund is calculated on NAV to NAV basis on the assumption that all dividends and distributions are reinvested, taking into account all charges which would have been payable upon such reinvestment.

The figures shown relate to past performance. Past performance is not a reliable indicator of future performance. Markets could develop very differently in the future. It can help you to assess how the fund has been managed in the past

Performance is shown on a Net Asset Value (NAV) basis, with gross income reinvested where applicable. The return of your investment may increase or decrease as a result of currency fluctuations if your investment is made in a currency other than that used in the past performance calculation. Source: Blackrock

All currency hedged share classes of this fund use derivatives to hedge currency risk. The use of derivatives for a share class could pose a potential risk of contagion (also known as spill-over) to other share classes in the fund. The fund’s management company will ensure appropriate procedures are in place to minimise contagion risk to other share class. Using the drop down box directly below the name of the fund, you can view a list of all share classes in the fund – currency hedged share classes are indicated by the word “Hedged” in the name of the share class. In addition, a full list of all currency hedged share classes is available on request from the fund’s management company

Key Facts

Key Facts

Net Assets of Fund
as of 04-Dec-2025
USD 18,064,123
Fund Inception
07-Jun-2021
Fund Base Currency
USD
Benchmark
MSCI All Country World Net TR Index - in EUR (EUR)
Initial Charge
5.00%
ISIN
LU2372745807
Performance Fee
0.00%
Minimum Subsequent Investment
EUR 1000
Domicile
Luxembourg
Management Company
BlackRock (Luxembourg) S.A.
Dealing Settlement
Trade date + 3 days
Bloomberg Ticker
BNGHD2E
MAS ESG Fund
No
Share Class Inception Date
11-Aug-2021
Share Class Currency
EUR
Asset Class
Equity
SFDR Classification
Other
Management Fee
0.68%
Management Fee (incl. Distribution Fee, if any)
0.68%
Minimum Initial Investment
EUR 100000
Use of Income
Accumulating
Regulatory Structure
UCITS
Morningstar Category
Sector Equity Healthcare
Dealing Frequency
Daily, forward pricing basis
SEDOL
BMW7TR2

Portfolio Characteristics

Portfolio Characteristics

Number of Holdings
as of 28-Nov-2025
125
P/E Ratio
as of 28-Nov-2025
30.54
5Y Annualised Volatility
as of -
-
Standard Deviation (3y)
as of 30-Nov-2025
15.58%
P/B Ratio
as of 28-Nov-2025
4.28
Since Share Inception – Annualised Volatility
as of 30-Nov-2025
16.19

Ratings

Ratings

Morningstar Rating

4 stars
As of 30-Nov-2025

Holdings

Holdings

as of 28-Nov-2025
Name Weight (%)
MEDTRONIC PLC 3.40
JOHNSON & JOHNSON 3.26
ABBOTT LABORATORIES 3.16
ROCHE HOLDING PAR AG 3.05
EXACT SCIENCES CORP 2.93
Name Weight (%)
EDWARDS LIFESCIENCES CORP 2.64
GUARDANT HEALTH INC 2.63
GILEAD SCIENCES INC 2.36
BIOGEN INC 2.28
IQVIA HOLDINGS INC 2.23

Exposure Breakdowns

Exposure Breakdowns

as of 28-Nov-2025

% of Weight

Type Fund Benchmark Net
as of 28-Nov-2025

% of Weight

Type Fund Benchmark Net
as of 28-Nov-2025

% of Weight

Type Fund Benchmark Net
Geographic exposure relates principally to the domicile of the issuers of the securities held in the product, added together and then expressed as a percentage of the product’s total holdings. However, in some instances it can reflect the country where the issuer of the securities carries out much of their business.
as of 28-Nov-2025

% of Weight

Type Fund Benchmark Net
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management. Allocations are subject to change.
Due to rounding, the total may not be equal to 100%

Pricing & Exchange

Pricing & Exchange

Share Class Currency NAV NAV Amount Change NAV % Change NAV As Of 52wk High 52wk Low ISIN
D2 EUR 8.79 -0.02 -0.23 04-Dec-2025 8.99 6.61 LU2372745807
A2 Hedged HKD 94.05 -0.12 -0.13 04-Dec-2025 95.58 68.23 LU2310091249
D2 USD 10.26 -0.01 -0.10 04-Dec-2025 10.42 7.30 LU2310090514
A2 USD 9.88 -0.01 -0.10 04-Dec-2025 10.04 7.07 LU2310090431
A2 Hedged SGD 9.15 -0.01 -0.11 04-Dec-2025 9.30 6.67 LU2310091165
A2 EUR 8.47 -0.01 -0.12 04-Dec-2025 8.66 6.40 LU2310090944

Portfolio Managers

Portfolio Managers

Erin Xie
Erin Xie
Xiang Liu
Xiang Liu

ESG Integration

ESG Integration

BlackRock considers many investment risks in our processes. In order to seek the best risk-adjusted returns for our clients, we manage material risks and opportunities that could impact portfolios, including financially material Environmental, Social and/or Governance (ESG) data or information, where available. See our Firm Wide ESG Integration Statement for more information on this approach and fund documentation for how these material risks are considered within this product, where applicable.

Documents

Documents